StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
OSTX

OS Therapies Incorporated

OSTX NYSE Pharmaceutical Preparations EDGAR ↗
$1.55
-0.01 -0.64%

Key statistics

from XBRL data in SEC filings
Market cap
$69.0M
Revenue (TTM)
Net income (TTM)
-$35.3M
EPS (TTM)
$-1.07
P/E ratio
Dividend yield
Free cash flow
-$14.7M
Cash
$918K
Total assets
$7.30M
Gross margin
52-week range
$1.15 – $2.57

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Terminated a material agreement Jul 29, 2026 8-K/A AMENDMENT NO. 1 TO FORM 8-K Jul 7, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Other events Jul 2, 2026 10-Q Quarter ended 2026-03-31 May 18, 2026 8-K Regulation FD disclosure Apr 30, 2026 8-K Entered a material agreement; Other events Apr 2, 2026 8-K Other events Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 6, 2026 8-K Other events Feb 13, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change; Shareholder vote results Oct 21, 2025 8-K Regulation FD disclosure; Other events Oct 17, 2025 8-K Other events Sep 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 2, 2025 8-K Terminated a material agreement; Other events Aug 26, 2025 8-K Results of operations (earnings release) Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 18, 2025 8-K Amended charter or bylaws Aug 15, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 14, 2025 8-K Entered a material agreement; Unregistered sale of equity Jun 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 24, 2025 8-K Results of operations (earnings release) May 16, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Completed an acquisition or disposition; Unregistered sale of equity; Other events Apr 15, 2025 8-K Shareholder vote results Apr 9, 2025 8-K Other events Apr 2, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Jan 29, 2025 8-K Other events Jan 15, 2025 8-K Entered a material agreement; Unregistered sale of equity Jan 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 3, 2025 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Dec 30, 2024 8-K Results of operations (earnings release) Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 15, 2024 8-K Entered a material agreement; Unregistered sale of equity Nov 1, 2024 8-K Director or officer change Oct 28, 2024 8-K Other events Aug 22, 2024